Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Akorn, Inc.’s acquisition of VersaPharm Inc. and its parent company, VPI Holdings Corp., would have likely been anticompetitive.
Following public comment periods, the Federal Trade Commission has approved four applications by Service Corporation International (SCI) to divest certain funeral and cemetery assets, as required under the FTC’s May 2014 order settling charges that SCI’s acquisition of Stewart Enterprises, Inc.
Federal Trade Commission Chairwoman Edith Ramirez has signed an antitrust cooperation agreement with the Colombian antitrust agency on behalf of the FTC. The agreement also was signed by Bill Baer, Assistant Attorney General in charge of the Department of Justice’s Antitrust Division, and went...
The PNO handles Hart-Scott-Rodino Premerger Notification Filings for well over a thousand transactions each year. When you submit an HSR Form with all the required information, the PNO can quickly review the filing, and if necessary, forward it to the investigative staff who will...
Sent Wednesday, June 25, 2014 10:11AM
To: Verne, B. Michael Walsh, Kathryn E.
Subject: HSR UPE Question
Dear Mike and Kathryn,
I have a very brief UPE related question I was hoping you could provide guidance on.
Facts: A client will use two Fonds...
Sent: Thursday, June 19, 2014 1:35 PM
To: Verne, B. Michael
Subject: Question re Ordinary Course Exemption
We are looking at the application of the used durable goods prong of the ordinary course exemption, Rule 802.1(d)(3),to a proposed transaction and...
Sent Wednesday, June 18, 2014 3:57PM
To: Verne, B. Michael
Cc: Walsh, Kathryn E.
Subject: HSR Questions
I understand from another law firm that the PNO agree that a transaction as described below was exempt and I want to confirm that it is still the current...
I recently spoke at a conference at the American Antitrust Institute.
Brief of the United States Department of Justice, Federal Trade Commission, Department of State, and Department of Commerce before the U.S. Court of Appeals for the Seventh Circuit addressing the proper application of the provisions of the Foreign Trade Antitrust Improvements Act of...
FTC alleges that AbbVie Inc. and Besins Healthcare Inc. filed baseless patent infringement lawsuits against potential generic competitors to delay the introduction of lower-priced versions of AndroGel.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Actavis plc’s acquisition of Forest Laboratories, Inc. would likely be anticompetitive.
Following a public comment period, the Federal Trade Commission has approved an application submitted by Franchise Services of North America, Inc. (FSNA) to sell two former Advantage Rent A Car airport rental car concessions, neither of which is currently operating. FSNA will sell assets located...
The Federal Trade Commission rejected a proposed settlement agreement with Phoebe Putney Health System, Inc., and returned the matter to administrative court to assess whether Phoebe’s 2011 merger with rival hospital Palmyra Park Hospital, Inc. in Albany, Georgia violated the antitrust laws.
As the calendar makes clear, summer is nearly over. For some, the transition to fall provokes thoughts of falling leaves, sharpened pencils, and warm beverages. For others, the end of summer means mulling over player rankings, sleepers, and early round strategies. While others have...
Following a public comment period, the Federal Trade Commission has approved final orders settling charges that two Internet resellers of UPC barcodes, which are used by retailers to scan prices and maintain inventories, invited competitors to join in a collusive scheme to raise the prices they...
Pharmaceutical company Prestige Brands Holdings, Inc., the maker of Dramamine, has agreed to divest assets and marketing rights for the over-the-counter motion sickness drug Bonine to settle Federal Trade Commission charges that Prestige’s proposed acquisition of Insight Pharmaceuticals...